Delivery Order SPE2DB22D2006-SPE2DB24FV7VP
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 10-320 MG TABLET 30S for a potential value of $1,504.44. The contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31,...
- Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide EXFORGE 10-160 MG TABLET 30S with a potential value of $11,125.92. The contract has a performance period through January 31, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE HCT 10-160-25 MG TAB 30S. This $1,225.14 award has a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order is part of a larger indefinite delivery contract (IDC) it holds with DLA, potentially valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 5-160 MG TABLET 30S. The $1,745.43 contract has a completion date of February 16, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will provide the pharmaceutical product from its Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,419.41 by the Defense Logistics Agency (DLA) to provide EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of January 26, 2024. This award is part of Amerisourcebergen Drug Corp's broader role as the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of EXFORGE 10-320 mg tablets. The contract has a potential value of $10,323.09 and a period of performance through February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designations were used. This contract appears to be issued under a larger...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,966.10 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of February 8, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December...
- The Defense Logistics Agency (DLA) awarded a $1,076.29 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide EXFORGE HCT 10-160-12.5 MG TAB 30S. This is a component of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a potential value of $1,071.78. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which does not have a set-aside designation....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EXFORGE 10-160 MG TABLET 30S. The firm fixed price contract has a ceiling value of $1,200.60 and an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV7VPDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 10-320 MG TABLET 30S. The contract has a potential value of $1,763.88 and a performance period through January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) that the company holds with DLA. The IDC has a maximum potential value of $999,999,999.00 and a period of performance through December 31, 2025, serving as the primary vehicle for Amerisourcebergen Drug Corp to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/30/24 |